| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Molekularpharmakologie, Medizinische Hochschule Hannover, Hannover, Germany;
DG Rheumatology, Hoechst Marion Roussel, Wiesbaden, Germany; and
Dompé Research Center, Via Campo di Pile, I-67100, L’Aquila, Italy
IL-1 binds to two types of receptors on the cell membrane, of which only type I (IL-1RI) transduces signals in concert with the coreceptor IL-1 receptor accessory protein (IL-1RAcP) while type II (IL-1RII) allegedly functions solely as ligand sink and decoy receptor without participating in IL-1 signaling. To investigate the regulatory role of IL-1RII on IL-1 responsiveness, a chimeric receptor encompassing the extracellular and transmembrane portions of IL-1RII and the cytoplasmic signal-transducing domain of IL-1RI was transfected into two murine EL-4-derived sublines that do or do not express IL-1RAcP, respectively. The chimeric receptor was able to transduce the IL-1 signal and induce IL-2 production only in the cell line which expressed IL-1RAcP, suggesting effective interaction between the extracellular domains of IL-1RII and IL-1RAcP in the presence of IL-1. The physical association of ligated IL-1RII with IL-1RAcP was proven by crosslinking experiments with radio-iodinated IL-1 and subsequent immunoprecipitations in normal human B cells and in EL-4 D6/76 cells transiently cotransfected with IL-1RII and IL-1RAcP, respectively. Based on these findings, it is proposed that upon IL-1 binding IL-1RII can recruit IL-1RAcP into a nonfunctional trimeric complex and thus modulate IL-1 signaling by subtracting the coreceptor molecule from the signaling IL-1RI. In this novel mechanism of coreceptor competition, the ratio between IL-1RII and IL-1RI becomes the central factor in determining the IL-1 responsiveness of a cell and the availability of IL-1RAcP becomes limiting for effective IL-1 signaling.
This article has been cited by other articles:
|
|
 |
|
  S. Ali, M. Huber, C. Kollewe, S. C. Bischoff, W. Falk, and M. U. Martin IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells PNAS, November 20, 2007; 104(47): 18660 - 18665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. I. Gomes, G. H. Esteves, A. F. Carvalho, E. B. Cristo, R. Hirata Jr., W. K. Martins, S. M. Marques, L. P. Camargo, H. Brentani, A. Pelosof, et al. Expression Profile of Malignant and Nonmalignant Lesions of Esophagus and Stomach: Differential Activity of Functional Modules Related to Inflammation and Lipid Metabolism Cancer Res., August 15, 2005; 65(16): 7127 - 7136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Jensen and A. S. Whitehead The 3' Untranslated Region of the Membrane-Bound IL-1R Accessory Protein mRNA Confers Tissue-Specific Destabilization J. Immunol., November 15, 2004; 173(10): 6248 - 6258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Levine Mechanisms of Soluble Cytokine Receptor Generation J. Immunol., November 1, 2004; 173(9): 5343 - 5348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mantovani, M. Locati, N. Polentarutti, A. Vecchi, and C. Garlanda Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR J. Leukoc. Biol., May 1, 2004; 75(5): 738 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Cui, F. N. Rouhani, F. Hawari, and S. J. Levine Shedding of the Type II IL-1 Decoy Receptor Requires a Multifunctional Aminopeptidase, Aminopeptidase Regulator of TNF Receptor Type 1 Shedding J. Immunol., December 15, 2003; 171(12): 6814 - 6819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bourke, A. Cassetti, A. Villa, E. Fadlon, F. Colotta, and A. Mantovani IL-1{beta} Scavenging by the Type II IL-1 Decoy Receptor in Human Neutrophils J. Immunol., June 15, 2003; 170(12): 5999 - 6005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dunne and L. A. J. O'Neill The Interleukin-1 Receptor/Toll-Like Receptor Superfamily: Signal Transduction During Inflammation and Host Defense Sci. Signal., February 25, 2003; 2003(171): re3 - re3. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bufler, T. Azam, F. Gamboni-Robertson, L. L. Reznikov, S. Kumar, C. A. Dinarello, and S.-H. Kim A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity PNAS, October 15, 2002; 99(21): 13723 - 13728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Muller, G. Peri, A. Doni, A. P. Perruchoud, R. Landmann, F. Pasqualini, and A. Mantovani High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration J. Leukoc. Biol., October 1, 2002; 72(4): 643 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Attur, M. N. Dave, M. Y. Leung, C. Cipolletta, M. Meseck, S. L. C. Woo, and A. R. Amin Functional Genomic Analysis of Type II IL-1{beta} Decoy Receptor: Potential for Gene Therapy in Human Arthritis and Inflammation J. Immunol., February 15, 2002; 168(4): 2001 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Debets, J. C. Timans, B. Homey, S. Zurawski, T. R. Sana, S. Lo, J. Wagner, G. Edwards, T. Clifford, S. Menon, et al. Two Novel IL-1 Family Members, IL-1{delta} and IL-1{epsilon}, Function as an Antagonist and Agonist of NF-{kappa}B Activation Through the Orphan IL-1 Receptor-Related Protein 2 J. Immunol., August 1, 2001; 167(3): 1440 - 1446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Cubitt, R. N. Lausch, and J. E. Oakes Synthesis of Type II Interleukin-1 Receptors by Human Corneal Epithelial Cells but not by Keratocytes Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 701 - 704. [Abstract] [Full Text]
|
|
|
|
|
|
R. Debets, J. C. Timans, T. Churakowa, S. Zurawski, R. de Waal Malefyt, K. W. Moore, J. S. Abrams, A. O'Garra, J. F. Bazan, and R. A. Kastelein IL-18 Receptors, Their Role in Ligand Binding and Function: Anti-IL-1RAcPL Antibody, a Potent Antagonist of IL-18 J. Immunol., November 1, 2000; 165(9): 4950 - 4956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Neumann, C. Kollewe, M. U. Martin, and D. Boraschi The Membrane Form of the Type II IL-1 Receptor Accounts for Inhibitory Function J. Immunol., September 15, 2000; 165(6): 3350 - 3357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. J. O'Neill The Interleukin-1 Receptor/Toll-like Receptor Superfamily: Signal Transduction During Inflammation and Host Defense Sci. Signal., August 8, 2000; 2000(44): re1 - re1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Jensen, M. Muzio, A. Mantovani, and A. S. Whitehead IL-1 Signaling Cascade in Liver Cells and the Involvement of a Soluble Form of the IL-1 Receptor Accessory Protein ,2 J. Immunol., May 15, 2000; 164(10): 5277 - 5286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Penton-Rol, S. Orlando, N. Polentarutti, S. Bernasconi, M. Muzio, M. Introna, and A. Mantovani Bacterial Lipopolysaccharide Causes Rapid Shedding, Followed by Inhibition of mRNA Expression, of the IL-1 Type II Receptor, with Concomitant Up-Regulation of the Type I Receptor and Induction of Incompletely Spliced Transcripts J. Immunol., March 1, 1999; 162(5): 2931 - 2938. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
